WNK3 and breast carcinoma: To address this context-dependent complexity, we identified activated PR target genes that were specifically regulated in cells expressing SUMO-deficient PRs (as markers of phosphorylated or hyperactivated PR transcriptional activity) and examined their average expression levels in the TCGA breast cancer patient cohort [5].